Altria at $76.75: What the New 52-Week High Really Signals

As seen on the 24/7 Wall St. homepage on October 29, 2026.

MO Altria
New 52-week high $76.75 +0.9% vs prior high · 2026-10-22
$79$64$50

Altria notched a new 52-week high at $76.75, 0.89% above the peak it set just a week ago, after its Q3 earnings beat. The defensive dividend name is now doing growth-stock work.

Continue ReadingShow less

Altria's stock touched $76.75 on October 29, clearing a 52-week peak it had set just a week earlier. Momentum is building quickly rather than grinding higher over months.

The catalyst is a Q3 earnings beat, giving investors a concrete reason to reprice the stock. A defensive, dividend-focused name earning a fresh annual high off an earnings report suggests the market is rethinking the growth ceiling.

Sponsored

The stock was trading in the low-to-mid $50s earlier in the 52-week window, so the run to current levels is a substantial rerating. The pace has steepened in recent weeks.

For income investors, a rising share price on a dividend name means total return is improving while the business shows it can still surprise to the upside on earnings. That combination is uncommon in the tobacco sector.

Sources

Mentioned: MO

Related Market Updates

Earnings · 2026 Q3 Sal Mancuso CEO
In smokeable products, PM USA grew operating companies income through its data-driven, total portfolio approach, with Cowboy Cut strengthening Marlboro's premium position and Basic continuing to gain share in discount. In smoke-free, Helix made meaningful progress by expanding on! PLUS 12-milligram nationwide, investing in brand-building initiatives and preparing for its next wave of innovation, which is now underway with the introduction of Blueberry Mint and Mango Pineapple flavor extensions…

Altria is defending both ends of the cigarette aisle at once, pushing Marlboro premium with Cowboy Cut while Basic takes discount share from trade-down smokers. On the smoke-free side, ON! PLUS 12-milligram is going nationwide with two new flavors, Altria's answer to higher-strength pouch rivals.

Read more
MO Altria
Q3 2026
EPS
$1.52
est $1.51 +0.7%
Revenue
$5.44B
est $5.31B +2.5%

Altria raised full-year adjusted EPS guidance to $5.66 to $5.74 even as domestic cigarette shipments fell an estimated 4%. Marlboro retail share slipped and pouch brand on! lost ground, so the earnings growth is leaning on levers outside the core brands.

Read more
Earnings · 2026 Q3 Sal Mancuso CEO
Our strong performance through the first nine months and confidence in our full-year plan allowed us to raise our earnings guidance for the year. We now expect to deliver adjusted diluted EPS in a range of $5.66 to $5.74, representing a growth rate of 4.5% to 6.0% from a base of $5.42 in 2025.

Altria is lifting its full-year earnings outlook with one quarter left, a rare move for a shrinking-volume cigarette business funding a 7%-plus dividend. The raise puts growth at the upper end of management's long-term algorithm, and income investors get the payout coverage question answered for 2026.

Read more
Earnings · 2026 Q3 Sal Mancuso CEO
Our highly cash-generative businesses supported significant returns to shareholders through dividends and share repurchases, while we continued to invest in support of our Vision. In August, we announced our 61st dividend increase in 57 years, and our Board of Directors (Board) recently authorized a $1 billion expansion of our existing share repurchase program.

Altria's board just added $1 billion to the repurchase authorization, stacking buybacks on top of a dividend the company has raised 61 times in 57 years. For income holders, the cash return engine is still intact heading into 2027.

Read more
MO Altria
New 52-week high $73.84 +0.1% vs prior high · 2026-07-29
$76$63$51

Altria just set a fresh 52-week high at $73.84, a level it has not touched since climbing from the low-$53s a year ago.

Read more